What Can Reinforcement Learning Models of Dopamine and Serotonin Tell Us about the Action of Antidepressants?
Computational Psychiatry · 2022-07-20 · 6 (1) · 166-188
DOI: 10.5334/cpsy.83 ↗At a glance
Übersichtsarbeit in Computational Psychiatry, published on 2022-07-20. Written by Denis C L Lan and 1 co-authors. Institution: Department of Experimental Psychology, University of Oxford, Oxford, GB. Cited 19 times so far (Crossref); 116 references. The full text is freely available in PubMed Central.
Abstract (original language)
Although evidence suggests that antidepressants are effective at treating depression, the mechanisms behind antidepressant action remain unclear, especially at the cognitive/computational level. In recent years, reinforcement learning (RL) models have increasingly been used to characterise the roles of neurotransmitters and to probe the computations that might be altered in psychiatric disorders like depression. Hence, RL models might present an opportunity for us to better understand the computational mechanisms underlying antidepressant effects. Moreover, RL models may also help us shed light on how these computations may be implemented in the brain (e.g., in midbrain, striatal, and prefrontal regions) and how these neural mechanisms may be altered in depression and remediated by antidepressant treatments. In this paper, we evaluate the ability of RL models to help us understand the processes underlying antidepressant action. To do this, we review the preclinical literature on the roles of dopamine and serotonin in RL, draw links between these findings and clinical work investigating computations altered in depression, and appraise the evidence linking modification of RL processes to antidepressant function. Overall, while there is no shortage of promising ideas about the computational mechanisms underlying antidepressant effects, there is insufficient evidence directly implicating these mechanisms in the response of depressed patients to antidepressant treatment. Consequently, future studies should investigate these mechanisms in samples of depressed patients and assess whether modifications in RL processes mediate the clinical effect of antidepressant treatments.
Subjects
Author keywords
Authors and institutions
- Department of Experimental Psychology, University of Oxford, Oxford, GB.
- Department of Psychiatry, University of Oxford, Oxford, GB.
ORCID profiles: Denis C L Lan, Michael Browning
Cite
APA
Lan, D. C. L., & Browning, M. (2022). What Can Reinforcement Learning Models of Dopamine and Serotonin Tell Us about the Action of Antidepressants?. Computational Psychiatry, 6(1), 166-188. https://doi.org/10.5334/cpsy.83
Vancouver
Lan DCL, Browning M. What Can Reinforcement Learning Models of Dopamine and Serotonin Tell Us about the Action of Antidepressants?. Computational Psychiatry. 2022;6(1):166-188. doi:10.5334/cpsy.83
BibTeX
@article{Lan2022,
author = {Lan, Denis C L and Browning, Michael},
title = {What Can Reinforcement Learning Models of Dopamine and Serotonin Tell Us about the Action of Antidepressants?},
journal = {Computational Psychiatry},
year = {2022},
volume = {6},
number = {1},
pages = {166--188},
doi = {10.5334/cpsy.83}
}
EUVIMED